EU LINKS
July 1st, 2004
BY KEITH NUTHALL
THE EUROPEAN Commission's ad hoc GMP inspections services group has proposed changes to the EU's pharmaceuticals good manufacturing guide regarding reference samples and retention samples (http://pharmacos.eudra.org/F2/pharmacos/docs/Doc2004/july/gmp_an19proposal.pdf). Also, the Commission has published guidelines on the filing of plasma master files and vaccine anti-gen master files by marketing approval applicants and holders, (http://pharmacos.eudra.org/F2/pharmacos/docs/Doc2004/july/vamfpmf.pdf).
THE EUROPEAN Commission's ad hoc GMP inspections services group has proposed changes to the EU's pharmaceuticals good manufacturing guide regarding reference samples and retention samples (http://pharmacos.eudra.org/F2/pharmacos/docs/Doc2004/july/gmp_an19proposal.pdf). Also, the Commission has published guidelines on the filing of plasma master files and vaccine anti-gen master files by marketing approval applicants and holders, (http://pharmacos.eudra.org/F2/pharmacos/docs/Doc2004/july/vamfpmf.pdf).
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.